Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-08-19

Clinical Trial Update: Effectiveness of Vitamin Supplementation in Treating People With Residual Symptoms of Schizophrenia [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the effectiveness of vitamin supplementation for residual symptoms in schizophrenia; results were posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vitamin supplementation (Vitamin supplementation)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Schizophrenia | Phase 4 | Status: COMPLETED | Results posted: 2014-08-19